Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BNC105
.
Show all posts
Showing posts with label
BNC105
.
Show all posts
Monday, July 20, 2015
Bionomics to present BNC105 trial results of metastatic renal cancer at Asian Oncology Summit
›
The data identify ferritin and IL-8 as two baseline biomarkers that correlate with an improved progression free survival (PFS) in patients...
Wednesday, May 13, 2015
Bionomics to present data from DisrupTOR-1 trial at ASCO Genitourinary Cancers Symposium
›
Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important additional data from the DisrupTOR-1 trial of BNC105 in patients wi...
›
Home
View web version
